证券研究报告·行业点评报告·机械设备 机械设备行业点评报告 ③松延动力：派出全系列产品阵容，参与小品《奶奶的最爱》，与蔡 明、王天放共同表演。机器人表演后空翻，会撒娇、讲笑话，并成功展示 仿生人脸。 ④银河通用：在贺岁微电影《我最难忘的今宵》中与沈腾、马丽等合 作，展示灵巧手能力，包括盘核桃、叠衣服、串烤肠、分拣玻璃渣等。 ◼ 两届春晚从《秧 BOT》到《武 BOT》，人形机器人从哪些方面完成"超 进化" 从《秧 BOT》到《武 BOT》，人形机器人从 哪些方面完成"超进化"？ 增持（维持） [Table_Tag] [投资要点 Table_Summary] ◼ 事件：人形机器人全面进军春晚，松延动力、宇树科技、魔法原子、银 河通用四家机器人公司分别亮相小品、武术、歌曲及微电影四大类节目 ①宇树：25 年蛇年春晚，宇树科技穿着花棉袄跳了一曲《秧 BOT》， 将人形机器人概念带入大众视野；26 年马年春晚，宇树科技搭配河南武术 学校，带来武术表演《武 BOT》，不仅能够连续花式翻桌跑酷，还上演全 球第一次机器人 Airflare 大回旋七周半，惊艳全场。 ②魔法原子：主会场上和易烊千玺等艺人共演《智造未来》，宜宾 ...

Group 1: CPI Overview - In January 2026, the overall CPI in the U.S. increased by 0.17%, below the expected 0.3% and the previous value of 0.30%[2] - The core CPI rose by 0.30%, matching expectations and up from 0.23% in the previous month[2] - Year-on-year CPI growth was 2.39%, lower than the expected 2.5% and the previous 2.68%[2] Group 2: Inflation Structure - The decline in overall CPI was primarily due to a significant drop in gasoline prices, which negatively impacted energy inflation[2] - Super core service inflation recorded a new high in year-on-year growth, indicating persistent inflationary pressure in this sector[2] - Excluding the unusual drop in used car prices, the core goods inflation is expected to rebound more significantly in the coming months[2] Group 3: Future Outlook - The expectation of expansive fiscal and monetary policies, along with seasonal impulses, is likely to support a phase of demand expansion in the U.S. economy in Q1 2026[2] - There are upward risks for non-farm payrolls and core CPI growth in February and March 2026, with the first interest rate cut by the Federal Reserve anticipated in June 2026[2] - Risks include potential overreach of Trump policies, excessive rate cuts leading to inflation rebound, and prolonged high-interest rates causing liquidity crises in the financial system[2]

Investment Rating - The industry investment rating is "Overweight," indicating an expected outperformance of the industry index relative to the benchmark by more than 5% in the next six months [55]. Core Insights - The automotive parts sector has shown a weekly increase of 1.69%, ranking third among automotive sectors, with a year-to-date increase of 4.94% [2][15]. - The robotics sector has increased by 2.27% this week, with a year-to-date increase of 2.54%, outperforming the automotive parts sector by 0.58% [2][27]. - The latest trading day PE (TTM) for the automotive parts sector is at the 85.68% historical percentile, while the PB (LF) is at the 79.62% historical percentile, indicating a favorable valuation [2][25]. - Key developments include the establishment of a joint venture between Sensata Technologies and Gree's Harmonic in North America, and the release of the Gino 1 warehouse robot by Geekplus [2][36]. Summary by Sections Automotive Parts Weekly Review - The automotive parts sector ranked third in the SW automotive index this week, with a trading volume increase and a positive trend since early February [15][22]. - The sector's PE and PB ratios have risen, indicating improved market sentiment and valuation [25][22]. Robotics Weekly Review - The robotics index has shown a modest increase, with trading activity at a low level compared to previous years [27][33]. - Recent product launches and technological advancements, such as the Gino 1 robot and Xiaomi's open-source robot model, highlight innovation in the sector [36][37]. Core Coverage Stock Tracking - Notable stock movements include Sensata Technologies (+17.05%) and Precision Forging Technology (+28.98%) [42]. - The forecast for Top Group indicates expected revenue of 28.75 to 30.35 billion yuan for 2025, with a projected net profit of 2.6 to 2.9 billion yuan [42][49]. Investment Recommendations - For the automotive parts sector, focus on companies with structural opportunities and those expanding into high-value markets, particularly in Europe, North America, and Southeast Asia [50]. - In the robotics sector, prioritize companies with clear growth trajectories and technological advancements, such as Top Group and Sensata Technologies [50].

Investment Rating - The report gives a "Buy" rating for the company, marking its first coverage [1]. Core Views - The clinical CRO industry is experiencing a recovery, with increasing demand driven by the global rise in innovative drug financing and the expansion of clinical trial outsourcing. The company is expected to benefit from this trend, with a significant increase in new orders and market share [8]. - The company has established itself as a leader in the clinical CRO market in China, with its market share rising from 8.7% in 2019 to 12.8% in 2023. This growth is attributed to the optimization of supply and the company's strong competitive position [8]. - The company's revenue and profit forecasts indicate a recovery, with expected revenues of 71.29 billion yuan in 2025, 80.19 billion yuan in 2026, and 93.27 billion yuan in 2027, alongside a substantial increase in net profit [8]. Summary by Sections Company Overview - Founded in 2004, the company has grown to become a leading clinical CRO in China, providing comprehensive services for the biopharmaceutical industry through self-built and acquired networks [14]. - The company's ownership structure is stable, with key founders holding significant shares and a management team experienced in top-tier biopharmaceutical companies [15]. Financial Analysis - The company has experienced revenue growth from 254 million yuan in 2012 to 6.603 billion yuan in 2024, with a compound annual growth rate (CAGR) of 28.5%. However, growth has slowed in 2023 and 2024 due to market conditions [19]. - The company’s gross margin has faced pressure, but a recovery is anticipated in 2026 as low-priced orders are cleared and new orders increase [22]. Industry Outlook - The global demand for CRO services is expected to grow, with the penetration rate of outsourced pharmaceutical R&D projected to exceed 50% by 2024 and reach approximately 65% by 2033 [43]. - The number of CRO companies in China has decreased significantly due to market consolidation, enhancing the competitive landscape for leading firms like the company [52]. Business Segments - The company operates primarily in two segments: Clinical Trial Technical Services (CTS) and Clinical Trial Related Services and Laboratory Services. CTS is the cornerstone of the business, covering all phases of clinical trials [54]. - The company has a strong international presence, with operations in 33 countries and a growing number of overseas projects, reflecting its commitment to global expansion [63].

Core Insights - The report emphasizes the strong growth potential in the testing services industry, particularly driven by emerging sectors such as commercial aerospace and new technologies [4][6] - The testing services sector is closely linked to macroeconomic growth, with a projected global market size of approximately 2.3 trillion RMB by 2024, reflecting a CAGR of about 6% from 2021 to 2024 [4][24] - In China, the testing services market is expected to reach around 487.6 billion RMB by 2024, with a CAGR of approximately 10.5% from 2015 to 2024, indicating a robust growth trajectory [5][24] Industry Overview - The testing, inspection, and certification (TIC) industry serves various sectors including consumer goods, industrial products, and pharmaceuticals, covering all stages from R&D to production and distribution [16][24] - The industry is characterized by a large market space and stable growth, with demand closely tied to macroeconomic trends and government regulations [20][24] - Emerging technologies such as AI, electric vehicles, and commercial aerospace are expected to create new testing demands, raising the entry barriers for new players [6][20] Company Performance - The report analyzes 19 listed companies in the testing services sector, highlighting their revenue and profit performance, with notable companies including Huace Testing, Guangdian Measurement, and Su Testing [2][11] - In the first three quarters of 2025, the testing services sector in China reported a revenue of 30.4 billion RMB, a decline of 7% year-on-year, but a growth of 3% when excluding companies heavily involved in medical testing [5][57] - Leading companies such as Huace Testing, Guangdian Measurement, and Su Testing demonstrated superior performance, with revenue growth rates of 7%, 12%, and 9% respectively, significantly outpacing the industry average [5][62] Market Dynamics - The testing services market is experiencing a structural shift, with a trend towards consolidation as larger firms gain market share and smaller firms face challenges [44][50] - The report notes that the majority of testing institutions in China are small and micro-sized, which limits their ability to withstand economic pressures [50][51] - Government policies are increasingly supporting the marketization and consolidation of testing institutions, aiming to enhance the overall quality and efficiency of the industry [51][53] Financial Metrics - The report indicates that the average gross margin for the testing services sector has improved, reaching 26.2% in the first three quarters of 2025, reflecting a recovery in profitability [63] - The accounts receivable turnover days have increased from 90 days in 2019 to 176 days in 2025, indicating a slowdown in cash flow and potential credit risks within the industry [67][68] - The report highlights that the proportion of accounts receivable in relation to revenue has risen to 50%, suggesting increasing challenges in managing receivables [71]

Investment Rating - The report recommends focusing on leading companies in the testing service industry, particularly those with strong capital, management, and research capabilities, such as Huace Testing, Guangdian Measurement, and Sutest [7] Core Insights - The testing service industry is closely related to macroeconomic growth, with significant market space and stable growth. The global testing service market is projected to reach approximately 2.3 trillion RMB by 2024, with a CAGR of about 6% from 2021 to 2024 [4][24] - China's testing service industry is expected to outpace GDP growth, with a projected market size of around 487.6 billion RMB in 2024, reflecting a CAGR of approximately 10.5% from 2015 to 2024 [5][24] - The industry is experiencing a structural shift, with emerging sectors such as AI, new energy vehicles, and commercial aerospace driving new demand for testing services [6][33] Summary by Sections Industry Overview - The testing, inspection, and certification (TIC) industry serves various sectors, including consumer goods, industrial products, and pharmaceuticals, covering all stages from R&D to production and distribution [16] - The demand for testing services is highly correlated with macroeconomic trends, with growth driven by global trade, increasing quality and safety standards, and stricter regulations [20][24] Market Performance - In 2025, the testing service sector in China reported revenues of 30.4 billion RMB, a year-on-year decline of 7%. Excluding companies with high medical testing proportions, the sector saw a 3% growth [5][57] - Leading companies like Huace Testing, Guangdian Measurement, and Sutest outperformed the industry average, with revenue growth rates of 7%, 12%, and 9% respectively in the first three quarters of 2025 [57][62] Emerging Opportunities - New technologies and industries, such as low-altitude economy and semiconductor sectors, are rapidly developing, creating new testing service demands. The investment threshold for laboratories in these areas is significantly higher than traditional sectors [6][33] - The report emphasizes the importance of focusing on leading companies that possess brand, capital, and management advantages to capitalize on these emerging opportunities [6][7] Competitive Landscape - The testing service market in China is characterized by a large number of small and medium-sized enterprises, with over 96% of testing institutions being micro-sized, which poses risks due to their limited capacity to withstand economic fluctuations [50][51] - The report predicts a trend towards consolidation in the industry, with resources increasingly concentrating in leading firms as smaller entities face challenges [50][51]

Investment Rating - The industry investment rating is "Accumulate" (Maintain) [1] Core Insights - Southwest Securities plans to raise 6 billion yuan through a private placement, which is expected to enhance its capital structure and accelerate business development, thereby improving its comprehensive financial service capabilities and market competitiveness [4] - The major shareholder, Yufu Holdings, is showing strong support by committing to subscribe for 1.5 billion yuan, which represents 25 billion yuan or 42% of the total issuance [4] - The funds raised will be allocated across various business areas, including wealth management (500 million yuan), investment banking (250 million yuan), asset management (900 million yuan), and securities investment (1.5 billion yuan) [4] - The financing is expected to dilute the Return on Equity (ROE) in the short term but is beneficial for the company's long-term strategic development [4] - The report indicates that the refinancing of securities firms may have been fully opened, with several firms completing or undergoing private placements since 2025 [4] Summary by Sections Industry Trends - Since 2025, there has been a significant increase in the number of securities firms engaging in refinancing, with four firms completing or in the process of private placements as of February 14, 2026 [4] - The report highlights that major shareholders are showing confidence in the future prospects of securities companies, as evidenced by their substantial subscription amounts [4] Financing Details - The planned private placement by Southwest Securities involves issuing up to 1.994 billion shares to no more than 35 specific investors, with a total fundraising target of 6 billion yuan [4] - The funds will be used for various purposes, including enhancing capital for wealth management, investment banking, asset management, and technology compliance [4][5]

Report Industry Investment Rating - Not provided in the content Core Viewpoints - This week (from February 9th to February 13th, 2026), there were no new secondary capital bonds issued in the inter - bank and exchange markets [1] - The weekly trading volume of secondary capital bonds this week was approximately 204.5 billion yuan, a decrease of 70.6 billion yuan compared to last week. The top three bonds in terms of trading volume were 25 Bank of China Secondary Capital Bond 02BC, 25 Bank of China Secondary Capital Bond 03A(BC), and 25 Agricultural Bank of China Secondary Capital Bond 04A(BC) [2] Summary by Relevant Catalogs Primary Market Issuance - No new secondary capital bonds were issued in the inter - bank and exchange markets from February 9th to February 13th, 2026 [1] Secondary Market Transactions - **Trading Volume**: The total weekly trading volume of secondary capital bonds was about 204.5 billion yuan, down 70.6 billion yuan from last week. The top three bonds in trading volume were 25 Bank of China Secondary Capital Bond 02BC (13.209 billion yuan), 25 Bank of China Secondary Capital Bond 03A(BC) (8.914 billion yuan), and 25 Agricultural Bank of China Secondary Capital Bond 04A(BC) (8.217 billion yuan) [2] - **Regional Trading Volume**: The top three regions in terms of trading volume were Guangdong Province (about 155.3 billion yuan), Shandong Province (about 16.5 billion yuan), and Shanxi Province (about 8.5 billion yuan) [2] - **Yield to Maturity**: As of February 13th, for 5Y secondary capital bonds, the yield to maturity of AAA -, AA +, and AA - rated bonds changed by - 6.56BP, - 6.91BP, and - 6.91BP respectively compared to last week; for 7Y bonds, the changes were - 8.84BP, - 5.66BP, and - 5.66BP; for 10Y bonds, the changes were - 6.53BP, - 4.86BP, and - 4.86BP [2] Top 30 Bonds with Valuation Deviation - **Overall Situation**: This week, the overall valuation deviation of the weekly trading average price of secondary capital bonds was not large. The proportion of discount transactions was greater than that of premium transactions, and the discount amplitude was larger than the premium amplitude [3] - **Discount Bonds**: The top three bonds with the highest discount rates were 17 Binhai Rural Commercial Secondary 01 (- 0.5685%), 23 Huaxing Bank Secondary Capital Bond 01 (- 0.4765%), and 22 Industrial and Commercial Bank of China Secondary Capital Bond 04B (- 0.4336%). The implicit ratings of China Central Depository & Clearing Co., Ltd. were mainly AAA -, AA, and AA +, and the bonds were mostly from Beijing, Shanghai, and Tianjin [3] - **Premium Bonds**: The top three bonds with the highest premium rates were 21 Huishang Bank Secondary 01 (0.5063%), 23 Hankou Bank Secondary Capital Bond 02 (0.4304%), and 23 Tianjin Bank Secondary Capital Bond 01 (0.3847%). The implicit ratings of China Central Depository & Clearing Co., Ltd. were mainly AA +, AAA -, and AA, and the bonds were mostly from Beijing, Zhejiang, and Fujian [3]

Financing Overview - In January 2026, the new social financing (社融) increased by 72,200 billion RMB, a year-on-year increase of 1,654 billion RMB[1] - Government bond financing contributed significantly with an increase of 9,764 billion RMB, up 2,831 billion RMB year-on-year, representing 13.5% of total social financing, the highest since 2021[4] - Corporate bond financing added 5,033 billion RMB, a year-on-year increase of 579 billion RMB, but slightly below the three-year average of 3,471 billion RMB[1] Loan Dynamics - Financial institutions issued 47,100 billion RMB in new loans in January 2026, which is 4,200 billion RMB less than the same period last year[2] - Corporate loans accounted for 44,500 billion RMB, down 3,300 billion RMB year-on-year, while household loans increased by 4,565 billion RMB, up 127 billion RMB year-on-year[2] - The total loan balance grew by 6.10% year-on-year, a decrease of 0.3 percentage points from the end of 2025[2] Money Supply Trends - As of January 2026, M1 grew by 4.9% year-on-year, an increase of 1.1 percentage points from the end of 2025[3] - M2 increased by 9.0% year-on-year, up 0.5 percentage points from the end of 2025[3] - Total deposits rose by 80,900 billion RMB, a year-on-year increase of 37,700 billion RMB, with significant contributions from fiscal deposits[3] Economic Signals - The increase in M1 and M2 indicates a strong liquidity supply and a positive signal for economic activity and capital market performance[4] - The structure of loans is improving, with a notable increase in short-term loans for enterprises, which rose by 20,500 billion RMB, up 3,100 billion RMB year-on-year[6] - The government’s proactive fiscal measures and moderate monetary easing are expected to continue supporting financing structures and economic growth[4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to achieve revenue growth in 2025, driven by the synergistic development of "robotics + vehicles + liquid cooling" [1] - The revenue forecast for 2025 is projected to be between 287.50 billion and 303.50 billion yuan, representing a year-on-year growth of 8.08% to 14.10% [8] - The net profit attributable to the parent company is expected to decline by 3.35% to 13.35%, with estimates ranging from 26.00 billion to 29.00 billion yuan [8] - The company plans to issue H shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and enhance overseas capacity [8] - The company has secured a 1.5 billion yuan order in its thermal management business, indicating strong demand in international markets [8] Financial Summary - Total revenue for 2023 is reported at 19.701 billion yuan, with a projected increase to 29.939 billion yuan in 2025, reflecting a growth rate of 12.55% [1] - The net profit for 2023 is 2.151 billion yuan, with a forecasted decline to 2.813 billion yuan in 2025, indicating a decrease of 6.25% [1] - The earnings per share (EPS) is expected to be 1.62 yuan in 2025, with a price-to-earnings (P/E) ratio of 44.48 [1] - The company’s total assets are projected to grow from 37.544 billion yuan in 2024 to 60.648 billion yuan in 2027 [9] - The company’s debt-to-equity ratio is expected to decrease from 47.84% in 2024 to 45.49% in 2027, indicating improved financial stability [9]